Medicare Enrolled

Dr. Keith Kadesky, M.D.

Urology Physician · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
8230 WALNUT HILL LN, Dallas, TX 75231
2146911902
In practice since 2006 (19 years)
NPI: 1396798211 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kadesky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kadesky? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kadesky

Dr. Keith Kadesky is an urology physician in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Kadesky performed 16,752 Medicare services across 5,227 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kadesky received a total of $4,427 from 53 pharmaceutical and/or device companies across 204 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kadesky is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 5% volume in TX$ $4,427 industry payments

Medicare Practice Summary

Medicare Utilization ↗
16,752
Medicare services
Top 5% in TX for urology physician
5,227
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~882 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Testosterone injection8,700$0$0
Urinalysis with microscopic exam1,691$3$6
Office visit, established patient (20-29 min)1,211$64$183
Blood draw (venipuncture)952$8$17
PSA test (prostate cancer screening)680$18$37
Bladder ultrasound after voiding536$8$22
Office visit, established patient (30-39 min)367$96$259
Chronic care management, first 20 min/month328$49$127
Ceftriaxone antibiotic injection216$0$1
Urine culture, bacterial colony count161$8$16
Leuprolide acetate (for depot suspension), 7.5 mg159$130$379
Urine culture, bacterial identification143$8$16
New patient office visit (45-59 min)125$118$336
Diagnostic exam of bladder and urethra using an endoscope103$187$494
Limited ultrasound scan behind abdominal cavity95$44$121
New patient office visit (30-44 min)83$81$226
Chronic care management, additional 20 min/month82$37$96
Insertion of lower leg neurostimulator electrode81$90$241
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings79$13$66
Testosterone (hormone) level, total79$25$52
Drug injection, under skin or into muscle69$11$29
Biopsy of prostate gland68$168$491
Ultrasound scan of pelvic region through rectum67$111$282
Antibiotic sensitivity test66$8$17
Bacterial culture, aerobic65$8$16
Complex measurement of pressure of urine flow in bladder with voiding pressure studies64$175$455
Insertion of device into abdomen with pressure and urine flow rate study64$99$250
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle53$26$70
Simple insertion of temporary bladder tube48$49$126
Comprehensive metabolic blood panel35$10$21
Complete ultrasound scan behind abdominal cavity33$86$224
Instillation of anti-cancer drug into bladder32$71$179
Electronic assessment of bladder emptying28$3$16
Basic metabolic blood panel28$8$17
Simple bladder irrigation and/or instillation24$60$156
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional21$18$48
Initial hospital admission, moderate complexity18$104$261
Office visit, established patient, complex (40-54 min)17$144$362
Complex measurement of pressure of urine flow in bladder16$143$363
Insertion of stent in ureter using an endoscope15$104$341
Hospital follow-up visit, low complexity15$40$99
Complicated insertion of bladder tube12$61$164
Complete laser vaporization of prostate including control of bleeding using an endoscope12$542$1,379
Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm11$226$567
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
58.7% medium
41.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,427
Total received (2018-2024)
Avg $632/year across 7 years
Top 40% in TX for urology physician
53
Companies
204
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,207 (95.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$220 (5.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,228
2023
$856
2022
$676
2021
$430
2020
$44
2019
$537
2018
$656

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$513
Edap Technomed Inc
$490
Dendreon Pharmaceuticals LLC
$325
PFIZER INC.
$323
Sumitomo Pharma America, Inc.
$282
ABBVIE INC.
$256
Bayer Healthcare Pharmaceuticals Inc.
$157
Janssen Biotech, Inc.
$148
Myovant Sciences Inc.
$118
Novartis Pharmaceuticals Corporation
$113
AbbVie Inc.
$103
TOLMAR Pharmaceuticals, Inc.
$101
Boston Scientific Corporation
$86
Amgen Inc.
$78
BioTissue Holdings, Inc.
$77
Coloplast Corp
$74
Merck Sharp & Dohme LLC
$69
Progenics Pharmaceuticals, Inc.
$60
Janssen Products, LP
$60
Ambu Inc.
$59
Tempus AI, Inc
$57
Blue Earth Diagnostics Limited
$52
Avadel Specialty Pharmaceuticals, LLC
$46
Verity Pharmaceuticals Inc.
$44
AKRIMAX PHARMACEUTICALS, LLC
$43
PROCEPT BioRobotics Corporation
$40
Rochester Medical Corporation
$39
Cook Medical LLC
$38
Olympus America Inc.
$38
Bayer HealthCare Pharmaceuticals Inc.
$36
Sun Pharmaceutical Industries Inc.
$36
UROGEN PHARMA, INC.
$34
AbbVie, Inc.
$33
UroGen Pharma, Inc.
$31
Mission Pharmacal Company
$27
BIOTISSUE HOLDINGS, INC.
$26
NeoTract Inc.
$26
Covidien LP
$25
Innovation Technologies Inc
$25
Merck Sharp & Dohme Corporation
$24
Pacira Pharmaceuticals Incorporated
$23
Integra LifeSciences Corporation
$22
Supernus Pharmaceuticals, Inc.
$21
Retrophin, Inc.
$20
UROVANT SCIENCES INC
$17
Endo Pharmaceuticals Inc.
$17
Medtronic, Inc.
$16
Metuchen Pharmaceuticals
$15
C. R. BARD, INC. & SUBSIDIARIES
$14
MEDIVATION FIELD SOLUTIONS LLC
$14
Allergan Inc.
$13
Myriad Genetic Laboratories, Inc.
$13
NxThera, Inc.
$9
Top 3 companies account for 30.0% of total payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM ROBOTIC SYSTEM · AVEED · Axumin · BOTOX · BOTOX THERAPEUTIC · CODMAN CERTAS · ELIGARD · ERLEADA · EXPAREL · Erleada · GEMTESA · IRRISEPT · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · Lupron · MYRBETRIQ · Myrbetriq · NEOX · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · POSLUMA · PROVENGE · PYLARIFY · Prolaris · Prolia · RESONANCE · REZUM · Rezum · SIGNIA · Sonicision · Stendra · TITAN · TLANDO · TOVIAZ · Titan · Trelstar · Uribel · UroLift · Urocit-K · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $26 per 100 Medicare services performed
Looking for a urology physician in Dallas?
Compare urology physicians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
131
Per 100K population
5.0
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kadesky is a mixed practice specialist, with above-average Medicare volume (top 5% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kadesky experienced with testosterone injection?
Based on Medicare claims data, Dr. Kadesky performed 8,700 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kadesky receive payments from pharmaceutical companies?
Yes. Dr. Kadesky received a total of $4,427 from 53 companies across 204 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kadesky's costs compare to other urology physicians in Dallas?
Dr. Kadesky's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kadesky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →